David A. Ramsay

2014

In 2014, David A. Ramsay earned a total compensation of $1.2M as Vice President and Chief Financial Officer at Halozyme Therapeutics, a 26% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$129,886
Option Awards$367,164
Salary$364,875
Stock Awards$371,385
Other$8,669
Total$1,241,979

Ramsay received $371.4K in stock awards, accounting for 30% of the total pay in 2014.

Ramsay also received $129.9K in non-equity incentive plan, $367.2K in option awards, $364.9K in salary and $8.7K in other compensation.

Rankings

In 2014, David A. Ramsay's compensation ranked 6,616th out of 13,032 executives tracked by ExecPay. In other words, Ramsay earned more than 49.2% of executives.

ClassificationRankingPercentile
All
6,616
out of 13,032
49th
Division
Manufacturing
2,418
out of 4,965
51st
Major group
Chemicals And Allied Products
815
out of 1,690
52nd
Industry group
Drugs
638
out of 1,369
53rd
Industry
Biological Products, Except Diagnostic Substances
122
out of 241
49th
Source: SEC filing on March 23, 2016.

Ramsay's colleagues

We found four more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2014.

2014

Helen Torley

Halozyme Therapeutics

Chief Executive Officer

2014

James Shaffer

Halozyme Therapeutics

Former Vice President and Chief Commercial Officer

2014

Jean Liu

Halozyme Therapeutics

General Counsel

2014

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

You may also like